NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The purpose of this NOFO is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders. Multidisciplinary teams of scientists and clinicians must focus on generating preclinical data that will lead to the development of biological, pharmacological, medical device and/or combination product interventions. The ultimate goal of this program is to make new technological, biological and pharmacological resources available to clinicians and their patients. The steps towards this goal should be clearly delineated in a series of milestones that support the development of a therapeutic or device that will lead to an Investigational New Drug (IND) or Investigational Device Exception (IDE) application to the U.S. Food and Drug Administration (FDA) and/or testing in a clinical trial.

    Eligibility

    Organization's Location
    ullamco nostrud, et proident, est sint, culpa in, cillum laboris, Lorem eiusmod
    Program Location
    sit consequat in pariatur aliquip proident commodo eiusmod magna exercitation
    Organization Type
    up to 3M

    Submission

    Visit Apply for more information.

    Similar grants

    5 of 5 free pages viewed this month
    Sign up to view this and 11K+ more grant opportunities
    Already have an account?Log in